help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology, doi:10.1210/en.2006-0684
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
147/12/5708    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gray, S. L.
Right arrow Articles by Vidal-Puig, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gray, S. L.
Right arrow Articles by Vidal-Puig, A.
Endocrinology Vol. 147, No. 12 5708-5714
Copyright © 2006 by The Endocrine Society

Decreased Brown Adipocyte Recruitment and Thermogenic Capacity in Mice with Impaired Peroxisome Proliferator-Activated Receptor (P465L PPAR{gamma}) Function

Sarah L. Gray1, Edoardo Dalla Nora1, Emma C. Backlund, Monia Manieri, Sam Virtue, Robert C. Noland, Stephen O’Rahilly, Ronald N. Cortright, Saverio Cinti, Barbara Cannon and Antonio Vidal-Puig

Departments of Clinical Biochemistry (S.L.G., E.D.N., S.V., S.O., A.V.-P.) and Medicine (S.O., A.V.-P.), University of Cambridge, Addenbrooke’s Hospital, Cambridge CB2 2QR, United Kingdom; The Wenner-Gren Institute (E.C.B., B.C.), The Arrhenius Laboratories F3, Stockholm University, SE-106 91 Stockholm, Sweden; Department of Normal Human Morphology (M.M., S.C.), Faculty of Medicine, Ancona University, 60020 Ancona, Italy; and Ward Sports Medicine Building and Brody School of Medicine (R.C.N., R.N.C.), Departments of Exercise and Sport Science and Physiology, East Carolina University, Greenville, North Carolina 27858

Address all correspondence and requests for reprints to: Antonio Vidal-Puig, Department of Clinical Biochemistry, University of Cambridge, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QR, United Kingdom. E-mail: ajv22{at}cam.ac.uk.


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice with a dominant-negative peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}) mutation (P465L) unexpectedly had normal amounts of adipose tissue. Here, we investigate the adipose tissue of the PPAR{gamma} P465L mouse in detail. Microscopic analysis of interscapular adipose tissue of P465L PPAR{gamma} mice revealed brown adipocytes with larger unilocular lipid droplets, indicative of reduced thermogenic capacity. Under conditions of cold exposure, the brown adipose tissue of the PPAR{gamma} P465L mice was less active, a fact reflected in decreased uncoupling protein 1 levels. Analysis of the white adipocytes confirmed their normal cytoarchitecture and development, yet classical white adipose depots of the P465L PPAR{gamma} mice had a striking reduction in brown adipocyte recruitment, a finding supported by reduced expression of UCP1 in the perigonadal adipose depot. Taken together, these data suggest that whole animal impairment of PPAR{gamma} alters the cellular composition of the adipose organ to a more "white" adipose phenotype. Physiologically, this impairment in brown adipocyte recruitment is associated with decreased nonshivering thermogenic capacity after cold acclimation as revealed by norepinephrine responsiveness. Our results indicate that maintenance of oxidative brown-like adipose tissue is more dependent on PPAR{gamma} function for development than white adipose tissue, an observation that may be relevant when considering PPAR{gamma}-dependent strategies for the treatment of obesity.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
ADIPOSE TISSUE IS primarily made up of adipocytes that store energy. However, two types of adipocytes, white and brown, are present in different proportions in most adipose tissue. In humans, the majority of adipocytes are white, energy-storing adipocytes, yet a small number of brown adipocytes can also be found in white fat depots, and these burn energy to produce heat. Rodents and other small mammals have adipose depots made up almost exclusively of these energy-burning adipocytes located in specific anatomical regions such as the interscapular depot (1, 2). Like in humans, brown adipocytes can also be found interspersed within white adipose tissue (WAT) (3, 4). It is unclear whether this phenomenon is the result of differentiation of specific preadipocyte precursors into brown adipocytes or alternatively from the transdifferentiation of white adipocytes to brown adipocytes (5, 6, 7, 8, 9, 10, 11).

Under certain environmental conditions, including cold and excess caloric intake, brown adipocytes become more active and increase in number (2, 10, 12). Given that the function of these brown adipocytes is to burn rather than store energy, increasing the number of brown adipocytes in WAT has been suggested as the basis for a novel strategy to prevent the development of obesity and related metabolic complications (13). Induction of brown adipocyte recruitment in WAT depots has been shown to decrease fat mass (14) and improve diet-induced insulin resistance in rodents (15) and humans (16).

A key protein to brown adipocyte function is uncoupling protein 1 (UCP1). UCP1 is expressed solely by brown adipocytes (17) and is required for uncoupling oxidative metabolism from the production of ATP, with the unused energy released in the form of heat. UCP1 expression and activity are increased in response to adrenergic stimulation, promoting increased energy expenditure. Several transcriptional regulators control UCP1 gene expression, including adrenergic activation of cAMP response binding protein (18), the CCAAT/enhancer binding proteins ß and {delta} (19), thyroid hormone receptors (20), and the peroxisome proliferator-activated receptors (PPARs). PPARs are members of the nuclear receptor superfamily and are known to regulate genes involved in lipid metabolism, carbohydrate metabolism, and energy balance (21). PPARs induce UCP1 expression through association with a PPAR response element in the proximal promoter of the UCP1 gene (22). The nuclear coactivator peroxisome proliferator-activated receptor {gamma} coactivator-1{alpha} (PGC1{alpha}) is induced in response to cold and associates with nuclear receptors to initiate pro-oxidative gene expression, including that of UCP1 (23). PPAR{gamma} agonism can induce the expression of UCP1 in brown adipocytes (24), and this induction of UCP1 improves the thermogenic capacity of the cell, demonstrated by the fact that norepinephrine-induced thermogenesis is enhanced in mice treated with PPAR{gamma} agonists (25, 26).

PPAR{gamma} is highly expressed in adipose tissue and has been shown to be important for the differentiation of both white and brown adipocytes (27, 28). PPAR{gamma} null mice die in utero at embryonic day 10 (28). As such models with tissue- and isoform- specific ablation of PPAR{gamma} have been used to examine PPAR{gamma} effects on adipogenesis and lipid and carbohydrate metabolism (29). Ablation of PPAR{gamma} specifically in mature adipocytes of mice results in progressive lipodystrophy. Specifically, the brown adipose tissue (BAT) in these mouse models is significantly reduced (30, 31) or absent (32). Isoform-specific ablation of PPAR{gamma}2 did not reduce the interscapular BAT depot (33, 34), yet brown adipocytes appeared to have reduced lipid content (33). Although these studies show that PPAR{gamma} is critical for BAT development and survival, the effects of PPAR{gamma} on brown adipocyte recruitment in WAT or the impact that these defects in brown adipocyte development have on adaptive thermogenesis were not examined in these mouse models.

Human patients with naturally occurring mutations in PPAR{gamma} have been identified (35, 36, 37). Patients with these dominant-negative mutations display a characteristic lipodystrophy, severe insulin resistance, and hypertension. Mouse models with equivalent heterozygous mutations in the ligand binding domain of PPAR{gamma} have been generated by homologous recombination (38, 39, 40) and provide an animal model with whole body impairment of PPAR{gamma} function. Due to the embryonically lethal phenotype associated with complete PPAR{gamma} knockout, a "clean" model of complete PPAR{gamma} ablation is not available. Here we use a dominant-negative PPAR{gamma} mouse model (P465L PPAR{gamma}) to demonstrate a role for PPAR{gamma} in the activation and recruitment of brown adipocytes in adipose tissue during cold exposure and its effects on thermogenic capacity.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Animals
Animals heterozygous for the dominant-negative P465L PPAR{gamma} mutation (P465L PPAR{gamma} mice) were generated by homologous recombination as previously described (40). Briefly, in embryonic stem cells, one wild-type allele for PPAR{gamma} was homologously recombined with a targeting construct that contained a C to T point mutation in exon 6 of the PPAR{gamma} gene. Chimeric mice with germline transmission of the heterozygous P465L PPAR{gamma} mutation were bred to produce mice heterozygous for the P465L PPAR{gamma} mutation. All animals used in these studies were fed a standard chow diet ad libitum and housed at 24 C with 12-h light, 12-h dark cycles unless otherwise stated. Groups of experimental P465L PPAR{gamma} mice were paired with age- and sex-matched littermate wild-type controls. All experimental procedures were approved by the University of Cambridge and the UK Home Office.

Histology
Tissues were removed and fixed directly in 10% formalin, or animals were perfused with 4% paraformaldehyde. Fixed samples were embedded in paraffin and sectioned using a microtome. Sections were stained with hematoxylin/eosin, and immunohistochemical detection of UCP1 in adipose tissue was performed using a primary antibody (UCP1 1:4000) and a biotinylated secondary antibody (Amersham, Little Chalfont, UK) detected by the Vectastain ABC kit (Vector Laboratories, Peterborough, UK).

Perigonadal (four sections per mouse) and sc inguinal (two sections per mouse) adipose sections were stained for UCP1 and subjected to semiquantitative evaluations. All UCP1 immunoreactive adipocytes present in the section were counted with a Zeiss light microscope at x200 magnification. The percentage of multilocular adipocytes present in perigonadal fat sections was calculated using a morphological imaging system (LUCIA, version 4.5, Nikon Instruments, Florence, Italy). For each experimental group, the percentage of adipocytes was calculated as the mean of the percentages of each animal derived from 800 random cells taken from four different areas per animal.

Gene expression profiling
Isolation of RNA and generation of cDNA.
Individual tissues were dissected and snap-frozen immediately in liquid nitrogen. Total RNA was extracted using RNA STAT60 (Tel-Test "B" Inc., Friendswood, TX). RNA (500 ng) was reverse transcribed to cDNA using MMLV reverse transcriptase (Promega, Southampton, UK).

Taqman analysis of gene expression.
The expression of key thermogenic genes and PPAR{gamma} in perigonadal (g) WAT, and interscapular BAT was analyzed using real-time PCR (TaqMAN, Applied Biosystems, Warrington, UK) with primers and probes designed to specific mRNAs (Sigma, Pampisford, UK) using Primer Express 2.0 (Applied Biosystems). PCR conditions were as follows: 50 C for 2 min; 95 C for 10 min; 40 cycles of 95 C for 15 sec and 60 C for 1 min. Values were normalized against 18S RNA and expressed as fold change compared with wild-type controls.

Western blots
Protein was extracted from tissue and quantified (Dc protein assay, Bio-Rad, Hemel Hempstead, UK). Protein (10 µg BAT or 30 µg gWAT) was denatured and reduced, run on an SDS-PAGE gel (10%), and transferred to polyvinylidene difluoride membrane. Protein expression was determined using a primary antibody to UCP1 (1:2000) (17) labeled with a goat antirabbit IgG secondary antibody (Dako, Glostrup, Denmark) and detected by the enhanced chemiluminescence detection system (Amersham). Protein expression was quantified by densitometry using AlphaEaseFC image analysis software.

Thermoneutrality
To examine the expression of genes under conditions of thermoneutrality, animals were housed at 30 C for 3 wk. Tissues collected at dissection were snap-frozen or fixed in 10% formalin.

Energy expenditure under cold acclimation
Four-month-old female P465L PPAR{gamma} mice and wild-type littermates were exposed to thermoneutrality (30 C) for 3 wk, placed at room temperature for 1 wk, and then exposed to 4 C for 3 wk. For both 30 C and 4 C acclimated animals, resting metabolic rate was measured (awake animals) at 30 C. In addition, norepinephrine-stimulated (1 mg/kg body weight) energy expenditure was evaluated in anesthetized (pentobarbital) animals at 33 C. Animals recovered from the anesthesia at 33 C before being transferred back to the acclimation temperature (4 C). Here they recovered from norepinephrine treatment for at least 72 h before tissue collection to ensure no influence of norepinephrine on gene and protein expression analysis. Oxygen consumption measurements are expressed as ml O2/min/kg0.75 (41). Housing of animals at the various temperatures and metabolic experiments were approved by the North Stockholm Animal Ethics Committee.

Statistical analysis
Data are presented as mean ± SEM. Statistical analyses using two-tailed unpaired t tests were performed, and significance was declared for P values less than 0.05 (GraphPad Instat 3 or Microsoft Excel).


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
P465L PPAR{gamma} mice have altered brown adipocyte morphology in the interscapular brown adipose depot
Histological analysis of the interscapular brown fat depot from animals raised at room temperature showed that P465L PPAR{gamma} mice had more lipid-replete BAT characterized by an increased number of unilocular adipocytes akin to white adipocytes (Fig. 1AGo). Gene expression of the adipocyte marker fatty acid binding protein, aP2, was reduced in interscapular BAT from P465L PPAR{gamma} mice compared with wild-type controls (Fig. 1BGo). Although there was no change in interscapular BAT UCP1 mRNA (Fig. 1BGo), P465L PPAR{gamma} brown adipocytes had a reduction in UCP1 immunostaining (Fig. 1AGo).


Figure 1
View larger version (80K):
[in this window]
[in a new window]
  		FIG. 1. A, Hematoxylin and eosin (H+E) and UCP1 immunohistological staining of interscapular BAT from P465L PPAR{gamma} (P465L) and wild-type (WT) mice raised at room temperature. B, Gene expression levels of the fatty acid binding protein, aP2, and UCP1 in interscapular BAT and perigonadal adipose tissue (gWAT) of P465L PPAR{gamma} mice compared with wild-type controls. Values are expressed as mean fold change ± SEM compared with wild-type gene expression. RT, Room temperature. C, Gross morphology of adipose tissue depots in the P465L PPAR{gamma} (P465L) and wild-type (WT) mice. 1, Interscapular BAT; 2, sc WAT; 3, gWAT. D, UCP1 immunostaining of WAT. E, The percentage of multilocular "brown-like" adipocytes in gWAT of P465L PPAR{gamma} mice raised at room temperature compared with wild-type controls. Significance is represented by * (P < 0.05) and ** (P < 0.01).

 
Impaired PPAR{gamma} function reduces the number of brown adipocytes infiltrating WAT depots
PPAR{gamma} is a key molecular regulator of adipose tissue differentiation. Unexpectedly, P465L PPAR{gamma} mice are able to develop normal amounts of adipose tissue (Fig. 1CGo) (39, 40) and have normal levels of aP2 mRNA in their gonadal white adipose depot (Fig. 1BGo). However, histological analysis revealed a striking difference in the cellular composition of the classic WAT depots (inguinal sc and g) in the P465L PPAR{gamma} mice, which had a smaller number of brown adipocytes compared with wild-type controls. The more "white" adipose tissue phenotype of the P465L PPAR{gamma} mice is observed grossly by the color of the adipose tissue from animals housed at room temperature (Fig. 1CGo). The percentage of multilocular adipocytes among unilocular adipocytes in the perigonadal depot of P465L PPAR{gamma} mice was less than one third of that found in the same depot of wild-type mice (Fig. 1Go, D and E). Furthermore, in the gWAT depot of the P465L PPAR{gamma} mice UCP1 mRNA levels were reduced (Fig. 1BGo).

Impaired activation of thermogenic genes in perigonadal adipose tissue depots in cold-acclimated PPAR{gamma} mice
Thermogenic induction of UCP1 and PGC1{alpha} gene expression in response to cold acclimation was not impaired in interscapular BAT of P465L PPAR{gamma} mice compared with wild-type controls (Fig. 2AGo) yet protein levels of UCP1 were somewhat reduced in the BAT of cold-acclimated P465L PPAR{gamma} mice compared with wild-type controls (Fig. 2DGo). In the gWAT of cold-acclimated P465L PPAR{gamma} mice, UCP1 and PGC1{alpha} mRNA and UCP1 protein levels were significantly reduced compared with wild-type controls (Fig. 2Go, A and D). These differences were not observed in BAT or gWAT of P465L PPAR{gamma} mice housed at thermoneutrality (Fig. 2BGo). Expression of the ß3 adrenergic receptor was not altered in BAT or gWAT of cold-acclimated P465L PPAR{gamma} mice. Adenylate cyclase (subunit 3) was not significantly changed in P465L BAT or gWAT of cold-acclimated mice, although in gWAT an observed 1.7-fold decrease in expression was close to significance (P = 0.062) (Fig. 2AGo).


Figure 2
View larger version (28K):
[in this window]
[in a new window]
  		FIG. 2. Altered expression of thermogenic genes in adipose tissue of cold-acclimated P465L PPAR{gamma} mice. A, UCP1, PGC1{alpha}, ß3 adrenergic receptor (B3), and subunit 3 of adenylate cyclase (AC) gene expression levels in interscapular BAT and perigonadal adipose tissue (gWAT) of mice acclimated to 4 C. B, Unaltered UCP1 gene expression levels in BAT and gWAT of P465L PPAR{gamma} mice housed at thermoneutrality (30 C) for 3 wk compared with wild-type controls. C, Quantification of WT PPAR{gamma} allele expression (mRNA) in cold-exposed wild-type and P465L PPAR{gamma} BAT and gWAT. D, UCP1 protein levels (assessed by quantified Western blots) in BAT (10 µg) and gWAT (30 µg) of animals housed at 4 C. Values are expressed as mean ± SEM. Significance is represented by ** (P < 0.01) or *** (P < 0.001).

 
Reduced thermogenic capacity of P465L PPAR{gamma} mice during cold exposure
Cold acclimation of P465L PPAR{gamma} mice to 4 C did not alter body weights or adipose tissue mass in P465L PPAR{gamma} mice compared with controls (Fig. 3Go, A and B). Despite decreased levels of UCP1 protein in cold-acclimated P465L PPAR{gamma} mice, both mutant and wild-type littermates had similar resting metabolic rates when acclimated to thermoneutrality or cold (4 C) (Fig. 3CGo), confirming that UCP1 activity does not contribute to resting metabolic rate (42). Norepinephrine treatment of thermoneutrality-acclimated animals, to determine the capacity for adrenergic-stimulated thermogenesis, did not reveal differences between wild-type and P465L PPAR{gamma} mice (Fig. 3CGo). However, administration of norepinephrine after cold acclimation showed that although the P465L PPAR{gamma} mice had significantly increased the magnitude of their response to norepinephrine compared with thermoneutrality, they showed a significantly reduced maximal thermogenic capacity compared with wild-type controls (Fig. 3CGo). The decrease in thermogenic capacity of about 25% was in good agreement with both the decrease in UCP1 protein levels seen in BAT of cold-acclimated animals (Fig. 2DGo) and the reduced expression of thermogenic genes in gWAT shown in the previous section of Results (Fig. 2AGo).


Figure 3
View larger version (19K):
[in this window]
[in a new window]
  		FIG. 3. Decreased thermogenic capacity of P465L PPAR{gamma} mice cold acclimated to 4 C. Normal body mass (A) and adipose tissue mass (B) in P465L PPAR{gamma} mice housed at 4 C for 3 wk compared with wild-type controls. C, Basal and norepinephrine-stimulated oxygen consumption in wild-type and P465L PPAR{gamma} mice housed at thermoneutrality (30 C) or 4 C. Values are expressed as mean ± SEM, and significance is represented by ** (P < 0.01).

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
It is well established that PPAR{gamma} is important for the development of BAT, as evidenced by the fact that mouse models with adipose-specific PPAR{gamma} (both PPAR{gamma}1 and PPAR{gamma}2) ablation have reduced or absent interscapular BAT (30, 31, 32). Furthermore, UCP1 is a known transcriptional target of PPAR{gamma} (27), and induction of UCP1 by PPAR{gamma} agonists increases the thermogenic capacity of brown adipocytes (25, 26). Here we show that in a mouse model with whole-animal impairment of PPAR{gamma} function (P465L PPAR{gamma} dominant-negative mutation), brown adipocyte recruitment and induction of UCP1 protein in brown adipocytes is impaired in response to cold.

The P465L PPAR{gamma} mutation is expressed in the heterozygous state and acts in a dominant-negative manner to impair wild-type PPAR{gamma} function. In vitro, characterization of the biochemical activity of ligand binding domain PPAR{gamma} mutants has previously been described. Briefly, presence of the mutant PPAR{gamma} impairs interaction with coactivators, enhances corepressor recruitment, and impairs ligand-dependent corepressor release (35, 43, 44, 45)

In general, the P465L PPAR{gamma} adipose tissue has a more "white-like" appearance, suggesting that brown adipocyte development is more severely affected by reduced PPAR{gamma} function than is the development of white adipocytes. These changes were associated with reduced thermogenic capacity. These results are in accordance with studies showing the opposite effects by pharmacological activation of PPAR{gamma} (24, 26, 46).

We investigated the effects of the P465L PPAR{gamma} mutation on adipose tissue morphology and whole animal thermogenesis. Microscopic analysis of interscapular adipose tissue from P465L PPAR{gamma} mice revealed that the cellular composition of this depot was altered compared with controls. The P465L PPAR{gamma} animals have less well-recruited interscapular BAT with an increased number of unilocular white-like adipocytes. In addition to the "white-like" phenotype of the interscapular BAT depot, recruitment of brown adipocytes in classic WAT depots of P465L PPAR{gamma} mice is strikingly impaired compared with wild-type controls. This was shown by a specific reduction in the number of brown adipocytes observed within the P465L PPAR{gamma} WAT.

This observation was confirmed by a highly significant reduction in the expression of the brown adipocyte-specific gene, UCP1, and the thermogenic coactivator, PGC1{alpha}, in the perigonadal adipose depot of cold-acclimated P465L PPAR{gamma} mice compared with wild-type controls. These changes in UCP1 and PGC1{alpha} mRNA levels in mice with the P465L PPAR{gamma} mutation fit well with the fact that PPAR{gamma} agonism can promote brown adipocyte recruitment in classical white adipose depots (46) and can induce UCP1 gene expression in adipocytes (24). These observations clearly show that in vivo PPAR{gamma} is required for full activation and recruitment of brown adipocytes when increased thermogenic capacity is required. The origin of the brown adipocytes in WAT depots, whether from transdifferentiation of mature white adipocytes or from adipocyte precursors within the white adipose depots, is yet to be defined.

The morphological and biochemical observations that demonstrate a more "white" adipose tissue are associated with a reduced maximal thermogenic output in P465L PPAR{gamma} mice when compared with wild-type controls as measured by norepinephrine-stimulated oxygen consumption. Gene expression levels of the ß3 adrenergic receptor are not altered in cold-acclimated BAT or WAT. In cold-acclimated WAT, we did see a trend of reduced adenylate cyclase expression, suggesting that there may be some reduction in the activation of this pathway, a finding that would be consistent with our physiological measurements of reduced thermogenic capacity.

The ability to increase the number of brown adipocytes within WAT and increase thermogenic capacity may be of potential medical value. Genetic modification in mouse to induce UCP1 expression in WAT prevents genetic obesity (47). As such, the development of brown adipocytes at the expense of white adipocytes is the scientific basis for a potential therapeutic strategy to treat obesity (13). The "white-like" phenotype of adipose tissue in the P465L PPAR{gamma} mouse suggests that although partial PPAR{gamma} activity in vivo may be enough to sustain the differentiation of white adipocytes, the complete differentiation of a brown phenotype requires fully functional PPAR{gamma}. This agrees with the idea that the potency of PPAR{gamma} agonists may alter the physiological effects incurred by PPAR{gamma} agonism through altered cofactor recruitment (48). In addition to improving insulin sensitivity, currently used pharmacological PPAR agonists cause weight gain. Our results support the concept that altering the potency of PPAR{gamma} agonists to specifically increase recruitment of brown adipocytes into classic WAT depots may have a therapeutic advantage to current thiazolidinedione treatment.

In summary, we present morphological and biochemical evidence that whole-animal impairment of PPAR{gamma} function preferentially alters brown adipocyte recruitment over white adipocyte development. Thus, in the P465L PPAR{gamma} mice, brown adipocytes have a more "white-like" appearance, are present at lower numbers in WAT depots, and have reduced expression of thermogenic proteins. Physiologically, these morphological and biochemical observations are associated with a reduced maximal thermogenic output by P465L PPAR{gamma} mice when compared with wild-type controls. Use of the P465L PPAR{gamma} mouse model has provided an in vivo model system to explore the physiological relevance of PPAR{gamma} in the development of brown adipocytes and in UCP1 induction. Analysis of the P465L PPAR{gamma} BAT provides compelling in vivo evidence that PPAR{gamma} plays a role in the normal recruitment and function of mammalian BAT.


   Acknowledgments
 
We acknowledge Sylvia Shelton and Helen Westby for their exceptional technical assistance.


   Footnotes
 
Funding for this work was provided by Diabetes UK and an Medical Research Council Career Development Award. Work completed in the laboratory of B.C. was supported by the Swedish Research Council. Salary support was provided by the Natural Sciences and Engineering Research Council of Canada (to S.L.G.) and the O. Arlotti Trust, Ferrara (to E.D.N.).

Disclosure Statement: S.L.G., E.D.N., S.V., M.M., E.C.B., R.C.N., R.N.C., S.C., B.C., and A.V.-P. have nothing to declare. S.O. consults for Merck, has received lecture fees from NovoNordisk, and has equity interests in Prosidion.

First Published Online September 15, 2006

1 S.L.G. and E.D.N. contributed equally to this work. Back

Abbreviations: BAT, Brown adipose tissue; g, perigonadal; PGC1{alpha}, peroxisome proliferator-activated receptor {gamma} coactivator-1{alpha}; PPAR, peroxisome proliferator-activated receptor; UCP1, uncoupling protein 1; WAT, white adipose tissue.

Received May 19, 2006.

Accepted for publication September 7, 2006.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Cannon B, Nedergaard J 2004 Brown adipose tissue: function and physiological significance. Physiol Rev 84:277–359[Abstract/Free Full Text]
  2. Cinti S 2005 The adipose organ. Prostaglandins Leukot Essent Fatty Acids 73:9–15[CrossRef][Medline]
  3. Himms-Hagen J, Cui J, Danforth Jr E, Taatjes DJ, Lang SS, Waters BL, Claus TH 1994 Effect of CL-316,243, a thermogenic ß3-agonist, on energy balance and brown and white adipose tissues in rats. Am J Physiol 266:R1371–R1382
  4. Cousin B, Cinti S, Morroni M, Raimbault S, Ricquier D, Penicaud L, Casteilla L 1992 Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J Cell Sci 103:931–942[Abstract/Free Full Text]
  5. Hansen JB, Jorgensen C, Petersen RK, Hallenborg P, De Matteis R, Boye HA, Petrovic N, Enerback S, Nedergaard J, Cinti S, te Riele H, Kristiansen K 2004 Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation. Proc Natl Acad Sci USA 101:4112–4117[Abstract/Free Full Text]
  6. Boeuf S, Klingenspor M, Van Hal NL, Schneider T, Keijer J, Klaus S 2001 Differential gene expression in white and brown preadipocytes. Physiol Genomics 7:15–25[Abstract/Free Full Text]
  7. Cinti S 2002 Adipocyte differentiation and transdifferentiation: plasticity of the adipose organ. J Endocrinol Invest 25:823–835[Medline]
  8. Coulter AA, Bearden CM, Liu X, Koza RA, Kozak LP 2003 Dietary fat interacts with QTLs controlling induction of Pgc-1 {alpha} and UCP1 during conversion of white to brown fat. Physiol Genomics 14:139–147[Abstract/Free Full Text]
  9. Granneman JG, Li P, Zhu Z, Lu Y 2005 Metabolic and cellular plasticity in white adipose tissue I: effects of ß3-adrenergic receptor activation. Am J Physiol Endocrinol Metab 289:E608–E616
  10. Murano I, Zingaretti MC, Cinti S 2005 The adipose organ of SV129 mice contains a prevalence of brown adipocytes and shows plasticity after cold exposure. Adipocytes 1:121–130
  11. Tiraby C, Tavernier G, Lefort C, Larrouy D, Bouillaud F, Ricquier D, Langin D 2003 Acquirement of brown fat cell features by human white adipocytes. J Biol Chem 278:33370–33376[Abstract/Free Full Text]
  12. Xue B, Coulter A, Rim JS, Koza RA, Kozak LP 2005 Transcriptional synergy and the regulation of Ucp1 during brown adipocyte induction in white fat depots. Mol Cell Biol 25:8311–8322[Abstract/Free Full Text]
  13. Tiraby C, Langin D 2003 Conversion from white to brown adipocytes: a strategy for the control of fat mass? Trends Endocrinol Metab 14:439–441[CrossRef][Medline]
  14. Tsukiyama-Kohara K, Poulin F, Kohara M, DeMaria CT, Cheng A, Wu Z, Gingras AC, Katsume A, Elchebly M, Spiegelman BM, Harper ME, Tremblay ML, Sonenberg N 2001 Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med 7:1128–1132[CrossRef][Medline]
  15. Cederberg A, Gronning LM, Ahren B, Tasken K, Carlsson P, Enerback S 2001 FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell 106:563–573[CrossRef][Medline]
  16. Yang X, Enerback S, Smith U 2003 Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. Obes Res 11:1182–1191[Medline]
  17. Cannon B, Hedin A, Nedergaard J 1982 Exclusive occurrence of thermogenin antigen in brown adipose tissue. FEBS Lett 150:129–132[CrossRef][Medline]
  18. Kozak UC, Kopecky J, Teisinger J, Enerback S, Boyer B, Kozak LP 1994 An upstream enhancer regulating brown-fat-specific expression of the mitochondrial uncoupling protein gene. Mol Cell Biol 14:59–67[Abstract/Free Full Text]
  19. Yubero P, Manchado C, Cassard-Doulcier AM, Mampel T, Vinas O, Iglesias R, Giralt M, Villarroya F 1994 CCAAT/enhancer binding proteins {alpha} and ß are transcriptional activators of the brown fat uncoupling protein gene promoter. Biochem Biophys Res Commun 198:653–659[CrossRef][Medline]
  20. Silva JE 2006 Thermogenic mechanisms and their hormonal regulation. Physiol Rev 86:435–464[Abstract/Free Full Text]
  21. Evans RM, Barish GD, Wang YX 2004 PPARs and the complex journey to obesity. Nat Med 10:355–361[CrossRef][Medline]
  22. Sears IB, MacGinnitie MA, Kovacs LG, Graves RA 1996 Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: regulation by peroxisome proliferator-activated receptor {gamma}. Mol Cell Biol 16:3410–3419[Abstract]
  23. Puigserver P, Ribot J, Serra F, Gianotti M, Bonet ML, Nadal-Ginard B, Palou A 1998 Involvement of the retinoblastoma protein in brown and white adipocyte cell differentiation: functional and physical association with the adipogenic transcription factor C/EBP{alpha}. Eur J Cell Biol 77:117–123[Medline]
  24. Digby JE, Montague CT, Sewter CP, Sanders L, Wilkison WO, O’Rahilly S, Prins JB 1998 Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes. Diabetes 47:138–141[Abstract]
  25. Thurlby PL, Wilson S, Arch JR 1987 Ciglitazone is not itself thermogenic but increases the potential for thermogenesis in lean mice. Biosci Rep 7:573–577[CrossRef][Medline]
  26. Sell H, Berger JP, Samson P, Castriota G, Lalonde J, Deshaies Y, Richard D 2004 Peroxisome proliferator-activated receptor {gamma} agonism increases the capacity for sympathetically mediated thermogenesis in lean and ob/ob mice. Endocrinology 145:3925–3934[Abstract/Free Full Text]
  27. Nedergaard J, Petrovic N, Lindgren EM, Jacobsson A, Cannon B 2005 PPAR{gamma} in the control of brown adipocyte differentiation. Biochim Biophys Acta 1740:293–304[Medline]
  28. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM 1999 PPAR{gamma} is required for placental, cardiac, and adipose tissue development. Mol Cell 4:585–595[CrossRef][Medline]
  29. Gray SL, Dalla Nora E, Vidal-Puig AJ 2005 Mouse models of PPAR-{gamma} deficiency: dissecting PPAR-{gamma}’s role in metabolic homoeostasis. Biochem Soc Trans 33:1053–1058[CrossRef][Medline]
  30. He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM 2003 Adipose-specific peroxisome proliferator-activated receptor {gamma} knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci USA 100:15712–15717[Abstract/Free Full Text]
  31. Imai T, Takakuwa R, Marchand S, Dentz E, Bornert JM, Messaddeq N, Wendling O, Mark M, Desvergne B, Wahli W, Chambon P, Metzger D 2004 Peroxisome proliferator-activated receptor {gamma} is required in mature white and brown adipocytes for their survival in the mouse. Proc Natl Acad Sci USA 101:4543–4547[Abstract/Free Full Text]
  32. Jones JR, Barrick C, Kim KA, Lindner J, Blondeau B, Fujimoto Y, Shiota M, Kesterson RA, Kahn BB, Magnuson MA 2005 Deletion of PPAR{gamma} in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci USA 102:6207–6212[Abstract/Free Full Text]
  33. Zhang J, Fu M, Cui T, Xiong C, Xu K, Zhong W, Xiao Y, Floyd D, Liang J, Li E, Song Q, Chen YE 2004 Selective disruption of PPAR{gamma}2 impairs the development of adipose tissue and insulin sensitivity. Proc Natl Acad Sci USA 101:10703–10708[Abstract/Free Full Text]
  34. Medina-Gomez G, Virtue S, Lelliott C, Boiani R, Campbell M, Christodoulides C, Perrin C, Jimenez-Linan M, Blount M, Dixon J, Zahn D, Thresher RR, Aparicio S, Carlton M, Colledge WH, Kettunen MI, Seppanen-Laakso T, Sethi JK, O’Rahilly S, Brindle K, Cinti S, Oresic M, Burcelin R, Vidal-Puig A 2005 The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-{gamma}2 isoform. Diabetes 54:1706–1716[Abstract/Free Full Text]
  35. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O’Rahilly S 1999 Dominant negative mutations in human PPAR{gamma} associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402:880–883[Medline]
  36. Savage DB, Tan GD, Acerini CL, Jebb SA, Agostini M, Gurnell M, Williams RL, Umpleby AM, Thomas EL, Bell JD, Dixon AK, Dunne F, Boiani R, Cinti S, Vidal-Puig A, Karpe F, Chatterjee VK, O’Rahilly S 2003 Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-{gamma}. Diabetes 52:910–917[Abstract/Free Full Text]
  37. Semple RK, Chatterjee VK, O’Rahilly S 2006 PPAR {gamma} and human metabolic disease. J Clin Invest 116:581–589[CrossRef][Medline]
  38. Freedman BD, Lee EJ, Park Y, Jameson JL 2005 A dominant negative peroxisome proliferator-activated receptor-{gamma} knock-in mouse exhibits features of the metabolic syndrome. J Biol Chem 280:17118–17125[Abstract/Free Full Text]
  39. Tsai YS, Kim HJ, Takahashi N, Kim HS, Hagaman JR, Kim JK, Maeda N 2004 Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPAR{gamma}. J Clin Invest 114:240–249[CrossRef][Medline]
  40. Gray SL, Dalla Nora E, Grosse J, Manieri M, Stoeger T, Medina-Gomez G, Burling K, Wattler S, Russ A, Yeo GSH, Chatterjee VK, O’Rahilly S, Voshol P, Cinit S, Vidal-Puig A 2006 Leptin deficiency unmasks the deleterious effects of impaired PPAR {gamma} function (P465L PPAR {gamma}) in mice. Diabetes 55:2669–2677[Abstract/Free Full Text]
  41. Alberts P, Johansson BG, McArthur RA 2005 Measurement and characterization of energy expenditure as a tool in the development of drugs for metabolic diseases, such as obesity and diabetes. Curr Protocols Pharmacol Suppl 28:5.39.1–5.39.15
  42. Golozoubova V, Cannon B, Nedergaard J 2006 UCP1 is essential for adaptive adrenergic nonshivering thermogenesis. Am J Physiol Endocrinol Metab 291:E350–E357
  43. Agostini M, Gurnell M, Savage DB, Wood EM, Smith AG, Rajanayagam O, Garnes KT, Levinson SH, Xu HE, Schwabe JW, Willson TM, O’Rahilly S, Chatterjee VK 2004 Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor {gamma}. Endocrinology 145:1527–1538[Abstract/Free Full Text]
  44. Gurnell M, Wentworth JM, Agostini M, Adams M, Collingwood TN, Provenzano C, Browne PO, Rajanayagam O, Burris TP, Schwabe JW, Lazar MA, Chatterjee VK 2000 A dominant-negative peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}) mutant is a constitutive repressor and inhibits PPAR{gamma}-mediated adipogenesis. J Biol Chem 275:5754–5759[Abstract/Free Full Text]
  45. Semple RK, Meirhaeghe A, Vidal-Puig AJ, Schwabe JW, Wiggins D, Gibbons GF, Gurnell M, Chatterjee VK, O’Rahilly S 2005 A dominant negative human peroxisome proliferator-activated receptor (PPAR){alpha} is a constitutive transcriptional corepressor and inhibits signaling through all PPAR isoforms. Endocrinology 146:1871–1882[Abstract/Free Full Text]
  46. Toseland CD, Campbell S, Francis I, Bugelski PJ, Mehdi N 2001 Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat. Diabetes Obes Metab 3:163–170[CrossRef][Medline]
  47. Kopecky J, Clarke G, Enerback S, Spiegelman B, Kozak LP 1995 Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J Clin Invest 96:2914–2923[Medline]
  48. Knouff C, Auwerx J 2004 Peroxisome proliferator-activated receptor-{gamma} calls for activation in moderation: lessons from genetics and pharmacology. Endocr Rev 25:899–918[Abstract/Free Full Text]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
147/12/5708    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gray, S. L.
Right arrow Articles by Vidal-Puig, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gray, S. L.
Right arrow Articles by Vidal-Puig, A.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals